Key result
Novel clinical-CT nomogram predicts short-term adverse outcomes in normotensive acute PE with an AUC of ~0.93.
Why the study?
It is important to identify deterioration in normotensive patients with acute pulmonary embolism on admission to improve risk stratification and management.
Can a risk-scoring tool accurately predict 30-day deterioration in normotensive patients with acute pulmonary embolism?
Cohort (n=845)
Randomized 2:1 to derivation and validation cohorts for model development
No
Can a risk-scoring tool accurately predict 30-day deterioration in normotensive patients with acute pulmonary embolism?
A novel web-based scoring tool incorporating clinical, laboratory, and CT parameters accurately predicts 30-day deterioration in normotensive patients with acute pulmonary embolism.
Answers are grounded in this paper and cite their sources.
Nomogram may aid risk stratification in normotensive PE; leaves open whether implementation improves outcomes.
Background: It is important to identify deterioration in normotensive patients with acute pulmonary embolism (PE). This study aimed to develop a tool for predicting deterioration among normotensive patients with acute PE on admission.Methods: Clinical, laboratory, and computed tomography parameters were retrospectively collected for normotensive patients with acute PE who were treated at a Chinese center from January 2011 to May 2020 on admission into the hospital. The endpoint of the deterioration was any adverse outcome within 30 days. Eligible patients were randomized 2:1 to derivation and validation cohorts, and a nomogram was developed and validated by the aforementioned cohorts, respectively. The areas under the curves (AUCs) with 95% confidence intervals (CIs) were calculated. A risk-scoring tool for predicting deterioration was applied as a web-based calculator.Results: The 845 eligible patients (420 men, 425 women) had an average age of 60.05±15.43 years. Adverse outcomes were identified for 81 patients (9.6%). The nomogram for adverse outcomes included heart rate, systolic pressure, N-terminal-pro brain natriuretic peptide, and ventricle/atrial diameter ratios at 4-chamber view, which provided AUC values of 0.925 in the derivation cohort (95% CI: 0.900–0.946, p<0.001) and 0.900 in the validation cohort (95% CI: 0.883–0.948, p<0.001). A risk-scoring tool was published as a web-based calculator (https://gaoyzcmu.shinyapps.io/APE9AD/).Conclusions: We developed a web-based scoring tool that may help predict deterioration in normotensive patients with acute PE.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2020) conducted a cohort in Acute pulmonary embolism (n=845). Nomogram risk-scoring tool vs. Bova score and 2019 ESC algorithm was evaluated on Adverse outcomes within 30 days (AUC 0.925, 95% CI 0.900-0.946, p=<0.001). A novel nomogram incorporating clinical, laboratory, and CT parameters accurately predicted 30-day adverse outcomes in normotensive patients with acute pulmonary embolism with an AUC of 0.925.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: